WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010138889) PEPTIDES FOR THE TREATMENT OF HCV INFECTIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/138889    International Application No.:    PCT/US2010/036682
Publication Date: 02.12.2010 International Filing Date: 28.05.2010
IPC:
C07K 5/06 (2006.01), A61K 38/05 (2006.01), A61P 31/14 (2006.01)
Applicants: CONCERT PHARMACEUTICALS, INC. [US/US]; 99 Hayden Avenue, Suite 500 Lexington, MA 02421 (US) (For All Designated States Except US).
MASSE, Craig, E. [US/US]; (US) (For US Only)
Inventors: MASSE, Craig, E.; (US)
Agent: ABELLEIRA, Susan, M.; HAMILTON, BROOK, SMITH & REYNOLDS, P.C. 530 Virginia Rd P.O. Box 9133 Concord, MA 01742-9133 (US)
Priority Data:
61/217,185 28.05.2009 US
Title (EN) PEPTIDES FOR THE TREATMENT OF HCV INFECTIONS
(FR) PEPTIDES DESTINÉS AU TRAITEMENT DES INFECTIONS PAR LE VHC
Abstract: front page image
(EN)This invention relates to novel compounds that are peptides derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel peptides that are deuterated derivatives of boceprevir. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating HCV infection.
(FR)Cette invention concerne de nouveaux composés qui sont des dérivés peptidiques et leurs sels pharmaceutiquement acceptables. De manière plus spécifique, cette invention concerne de nouveaux peptides qui sont des dérivés deutérés du bocéprévir. Cette invention a également pour objet des compositions contenant un ou plusieurs composés de cette invention et un support et l'utilisation des composés et des compositions divulgués dans des méthodes de traitement d'une infection par le VHC.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)